Bicycle Therapeutics PLC at Needham Healthcare Conference (Virtual) Transcript
Good morning, everyone. I'm Ami Fadia. I cover neuroscience and targeted oncology here at Needham. It's my pleasure to be hosting Bicycle Therapeutics for this next session here. We have many members of the team. (Conference Instructions)
Questions & Answers
With that, let me kick it off with a question for Kevin. Kevin, you guys recently presented some additional data on BT8009.
Perhaps you could -- if you could start with your overarching takeaway of what you thought the data told you and where you thought the biggest controversy seems to lie, just based on some of the questions you might be getting from investors.
Absolutely. Thanks, Ami, and to everyone, many thanks for joining the call. It's great to be here, really excited to tell you a little bit more about Bicycle.
Yeah, we presented an abstracted ACR a couple of days ago now. We were actually
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
